tradingkey.logo

Progyny Inc

PGNY
查看详细走势图
26.960USD
+0.330+1.24%
收盘 12/22, 16:00美东报价延迟15分钟
2.32B总市值
41.31市盈率 TTM

Progyny Inc

26.960
+0.330+1.24%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.24%

5天

+2.35%

1月

+4.25%

6月

+28.50%

今年开始到现在

+56.29%

1年

+88.01%

查看详细走势图

TradingKey Progyny Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Progyny Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗服务供应商行业排名8/78位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价29.10。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Progyny Inc评分

相关信息

行业排名
8 / 78
全市场排名
63 / 4582
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 11 位分析师
买入
评级
29.100
目标均价
+17.81%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Progyny Inc亮点

亮点风险
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
业绩高增长
公司营业收入稳步增长,连续3年增长48.33%
利润高增长
公司净利润处于行业前列,最新年度总收入1.17B美元
估值合理
公司最新PE估值40.80,处于3年历史合理位
机构减仓
最新机构持股88.02M股,环比减少24.51%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓,最新持仓市值1.50K

Progyny Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Progyny Inc简介

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
公司代码PGNY
公司Progyny Inc
CEOAnevski (Peter)
网址https://www.progyny.com/

常见问题

Progyny Inc(PGNY)的当前股价是多少?

Progyny Inc(PGNY)的当前股价是 26.960。

Progyny Inc的股票代码是什么?

Progyny Inc的股票代码是PGNY。

Progyny Inc股票的52周最高点是多少?

Progyny Inc股票的52周最高点是27.510。

Progyny Inc股票的52周最低点是多少?

Progyny Inc股票的52周最低点是13.960。

Progyny Inc的市值是多少?

Progyny Inc的市值是2.32B。

Progyny Inc的净利润是多少?

Progyny Inc的净利润为54.34M。

现在Progyny Inc(PGNY)的股票是买入、持有还是卖出?

根据分析师评级,Progyny Inc(PGNY)的总体评级为买入,目标价格为29.100。

Progyny Inc(PGNY)股票的每股收益(EPS TTM)是多少

Progyny Inc(PGNY)股票的每股收益(EPS TTM)是0.653。
KeyAI